Home › Hereditary Sensory and Autonomic Neuropathies › Pennsylvania › Philadelphia
Hereditary Sensory and Autonomic Neuropathies clinical trials in Philadelphia, PA
5 studies for Hereditary Sensory and Autonomic Neuropathies are looking for participants at sites in and around Philadelphia (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Carboplatin or Olaparib for BRcA Deficient Prostate Cancer
RecruitingPhase 2
- Philadelphia MultiService Center, Philadelphia, PA, Philadelphia
A Study of ROC-101 in Patients With Pulmonary Arterial Hypertension (PAH) and Pulmonary Hypertension Associated With Interstitial Lung Disease (ILD-PH) (ROCSTAR STUDY)
RecruitingPhase 2
- Temple University, Philadelphia
A Study of ART0380 for the Treatment of Advanced or Metastatic Solid Tumors
RecruitingPhase 1/2
- University of Pennsylvania / Abramson Cancer Center, Philadelphia
- Thomas Jefferson University, Sidney Kimmel Cancer Center, Clinical Research Organization, Philadelphia
A Study to Evaluate the Safety and Tolerability of TOS-358 in Women With HR+ HER2- Breast Cancer
RecruitingPhase 1
- University of Pennsylvania, Philadelphia
The Cancer of the Pancreas Screening-5 CAPS5)Study
RecruitingPhase 3
- University of Pennsylvania, Philadelphia
Hereditary Sensory and Autonomic Neuropathies trials in other cities
- Arlington, VA7 studies
- San Antonio, TX7 studies
- Boston, MA6 studies
- Nashville, TN6 studies
- New York City, NY6 studies
- Houston, TX5 studies
- Portland, OR4 studies
- Pittsburgh, PA4 studies
- Ann Arbor, MI4 studies
- Washington, DC4 studies
- Los Angeles, CA3 studies
- Aurora, CO3 studies
Other studies in Philadelphia
- Cancer (all types)59 studies
- Breast Cancer56 studies
- Non-Small Cell Lung Cancer51 studies
- Metastatic Cancer46 studies
- Prostate Cancer44 studies
- Colorectal Cancer44 studies
- Ovarian Cancer44 studies
- Lung Cancer36 studies
- Acute Myeloid Leukemia34 studies
- Heart Failure31 studies
- Endometrial Cancer28 studies
- Depression26 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.